Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Formoterol fumarate 12mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Product containing formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Eformoterol fumarate dihydrate |
Is a |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Eformoterol fumarate 12micrograms inhalation capsules+inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Eformoterol fumarate dihydrate 12micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Eformoterol fumarate dihydrate 6micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Formoterol fumarate 8.5micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Formoterol 20micrograms inhalation solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Formoterol fumarate dihydrate (substance) |
Is a |
False |
Formoterol fumarate |
Inferred relationship |
Some |
|
Formoterol fumarate dihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Formoterol fumarate |
Inferred relationship |
Some |
|
Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate |
Inferred relationship |
Some |
1 |
Budesonide 250 microgram/mL and formoterol fumarate 10 microgram/mL suspension for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 500 microgram/1 milliliter and formoterol fumarate 10 microgram/1 milliliter conventional release suspension for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Formoterol fumarate |
Inferred relationship |
Some |
1 |
Product containing precisely budesonide 500 microgram/1 milliliter and formoterol fumarate 10 microgram/1 milliliter conventional release suspension for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Formoterol fumarate |
Inferred relationship |
Some |
1 |
Formoterol fumarate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Formoterol fumarate |
Inferred relationship |
Some |
|